Efforts to develop effective treatments for Alzheimer’s disease are increasingly moving away from a single-target approach and toward a more complex strategy inspired by advances in cancer therapy. Recent clinical trials — including those that did not achieve their intended outcomes — are reinforcing the idea that Alzheimer’s is driven by multiple biological pathways rather… Continue reading Alzheimer’s Drug Research Takes Cues From Cancer’s Multi-Target Strategy
